Ivax albuterol net margin will be 52%; company sees 1996 approval for Elmiron.
Executive Summary
IVAX ALBUTEROL GENERIC MDI PROFIT MARGIN OF 52% AFTER TAX is anticipated by the company, Ivax Chief Operating Officer and Health Care Group President Richard Pfenniger told the American Stock Exchange health care conference in New York City Jan. 18. The product is being manufactured by Ivax in Ireland. Ivax received approval for the first generic albuterol metered-dose inhaler Dec. 28 ("The Pink Sheet" Jan. 1, p. 3).